NeuroVirt develops an immersive virtual reality platform for motion rehabilitation, using AI-driven gaming experiences that monitor and correct patients' movements in real time. The solution focuses on upper-limb impairments and is designed for stroke survivors as well as people with traumatic brain injury, spinal cord injury, multiple sclerosis, Parkinson’s and musculoskeletal conditions. Its platform produces analytics and tracking data intended for clinical monitoring and to demonstrate patient outcomes. The company plans to use its recent funding to accelerate commercial growth in the UK and pursue contracts with healthcare providers in the US, while targeting broader EU market presence in 2025–2026. NeuroVirt projects the potential for a contract opportunity around $20M per annum and positions that as a route to fast ROI. The founder, Dr. Eve Gregoriou, is a Greek entrepreneur based in London with PhD research in stroke-specific motor rehabilitation from UCL.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2024